Cargando…

186. Prescriber-Led Antibiotic Timeout Alert Responses: A Retrospective Multicenter Study

BACKGROUND: An antibiotic time out is when a clinician is prompted to reevaluate antibiotic therapy for appropriateness after 48–72 hrs. The purpose of this study is to evaluate the impact of a prescriber-led electronic antibiotic timeout alert. METHODS: This was a retrospective cohort study conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Smoke, Steven, Secaras, Ellen, Crossen, Melissa, Patel, Gargi, Brophy, Alison, Clark, Alexander, Elbaga, Yasmine, Raja, Karan, Shah, Monica, Stone, Elizabeth, Lew, Indu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778230/
http://dx.doi.org/10.1093/ofid/ofaa439.230
_version_ 1783631086926954496
author Smoke, Steven
Secaras, Ellen
Crossen, Melissa
Patel, Gargi
Brophy, Alison
Clark, Alexander
Elbaga, Yasmine
Raja, Karan
Shah, Monica
Stone, Elizabeth
Lew, Indu
author_facet Smoke, Steven
Secaras, Ellen
Crossen, Melissa
Patel, Gargi
Brophy, Alison
Clark, Alexander
Elbaga, Yasmine
Raja, Karan
Shah, Monica
Stone, Elizabeth
Lew, Indu
author_sort Smoke, Steven
collection PubMed
description BACKGROUND: An antibiotic time out is when a clinician is prompted to reevaluate antibiotic therapy for appropriateness after 48–72 hrs. The purpose of this study is to evaluate the impact of a prescriber-led electronic antibiotic timeout alert. METHODS: This was a retrospective cohort study conducted at seven hospitals of a health system. The alert prompts prescribers to reevaluate antibiotic therapy after > 72 hours upon opening the electronic chart. Prescribers can then choose to “Continue”, “Renew”, “Discontinue” or “Defer” for each antibiotic. The alert fires for every time the chart is opened, for every prescriber, every time any antibiotic has been active for > 72 hours and no action response (i.e., “Continue”, “Renew”, “Discontinue”) has been selected. This was a 6 month study from November 1, 2018 – April 30, 2019. The primary outcome measure was the percentage of patients having > 1 antibiotic discontinued via the electronic antibiotic timeout alert. Secondary outcomes included frequency of timeout alerts per patient, and percentage of discontinuations per response, by drug, by indication and by patient age. RESULTS: A total of 213950 alerts fired for 13263 patients during the study period. 94.2% and 0.4% of responses were “Defer” and “Discontinue”, respectively. The average number of alerts per patient was 16.1. The percentage of patients who had at least one discontinuation was 5.3%. 38.2% of patients had no response other than “Defer”. There were a total of 10306 action responses, 4.8% of which were “Discontinue”. Among action responses, discontinue rates for the indications of “COPD exacerbation”, “Prophylaxis, Surgical/Procedural”, “Prophylaxis, Immunosuppression”, “Osteomyelitis” were 9.6%, 12%, 1.3% and 1%, respectively. Azithromycin and trimethoprim/sulfamethoxazole had discontinuation rates of 9.3% and 0.9%, respectively. Patient age had a significant impact on discontinuation rates with rates of 4.7%, 3.5%, and 10.9% for patients > 18, 2–17 and < 2 years of age (p< 0.001). CONCLUSION: An electronic antibiotic timeout alert implemented at seven hospitals was largely ignored. This alert may be refined by limiting it to antibiotic orders with specific features associated with higher rates of discontinuation. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7778230
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77782302021-01-07 186. Prescriber-Led Antibiotic Timeout Alert Responses: A Retrospective Multicenter Study Smoke, Steven Secaras, Ellen Crossen, Melissa Patel, Gargi Brophy, Alison Clark, Alexander Elbaga, Yasmine Raja, Karan Shah, Monica Stone, Elizabeth Lew, Indu Open Forum Infect Dis Poster Abstracts BACKGROUND: An antibiotic time out is when a clinician is prompted to reevaluate antibiotic therapy for appropriateness after 48–72 hrs. The purpose of this study is to evaluate the impact of a prescriber-led electronic antibiotic timeout alert. METHODS: This was a retrospective cohort study conducted at seven hospitals of a health system. The alert prompts prescribers to reevaluate antibiotic therapy after > 72 hours upon opening the electronic chart. Prescribers can then choose to “Continue”, “Renew”, “Discontinue” or “Defer” for each antibiotic. The alert fires for every time the chart is opened, for every prescriber, every time any antibiotic has been active for > 72 hours and no action response (i.e., “Continue”, “Renew”, “Discontinue”) has been selected. This was a 6 month study from November 1, 2018 – April 30, 2019. The primary outcome measure was the percentage of patients having > 1 antibiotic discontinued via the electronic antibiotic timeout alert. Secondary outcomes included frequency of timeout alerts per patient, and percentage of discontinuations per response, by drug, by indication and by patient age. RESULTS: A total of 213950 alerts fired for 13263 patients during the study period. 94.2% and 0.4% of responses were “Defer” and “Discontinue”, respectively. The average number of alerts per patient was 16.1. The percentage of patients who had at least one discontinuation was 5.3%. 38.2% of patients had no response other than “Defer”. There were a total of 10306 action responses, 4.8% of which were “Discontinue”. Among action responses, discontinue rates for the indications of “COPD exacerbation”, “Prophylaxis, Surgical/Procedural”, “Prophylaxis, Immunosuppression”, “Osteomyelitis” were 9.6%, 12%, 1.3% and 1%, respectively. Azithromycin and trimethoprim/sulfamethoxazole had discontinuation rates of 9.3% and 0.9%, respectively. Patient age had a significant impact on discontinuation rates with rates of 4.7%, 3.5%, and 10.9% for patients > 18, 2–17 and < 2 years of age (p< 0.001). CONCLUSION: An electronic antibiotic timeout alert implemented at seven hospitals was largely ignored. This alert may be refined by limiting it to antibiotic orders with specific features associated with higher rates of discontinuation. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7778230/ http://dx.doi.org/10.1093/ofid/ofaa439.230 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Smoke, Steven
Secaras, Ellen
Crossen, Melissa
Patel, Gargi
Brophy, Alison
Clark, Alexander
Elbaga, Yasmine
Raja, Karan
Shah, Monica
Stone, Elizabeth
Lew, Indu
186. Prescriber-Led Antibiotic Timeout Alert Responses: A Retrospective Multicenter Study
title 186. Prescriber-Led Antibiotic Timeout Alert Responses: A Retrospective Multicenter Study
title_full 186. Prescriber-Led Antibiotic Timeout Alert Responses: A Retrospective Multicenter Study
title_fullStr 186. Prescriber-Led Antibiotic Timeout Alert Responses: A Retrospective Multicenter Study
title_full_unstemmed 186. Prescriber-Led Antibiotic Timeout Alert Responses: A Retrospective Multicenter Study
title_short 186. Prescriber-Led Antibiotic Timeout Alert Responses: A Retrospective Multicenter Study
title_sort 186. prescriber-led antibiotic timeout alert responses: a retrospective multicenter study
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778230/
http://dx.doi.org/10.1093/ofid/ofaa439.230
work_keys_str_mv AT smokesteven 186prescriberledantibiotictimeoutalertresponsesaretrospectivemulticenterstudy
AT secarasellen 186prescriberledantibiotictimeoutalertresponsesaretrospectivemulticenterstudy
AT crossenmelissa 186prescriberledantibiotictimeoutalertresponsesaretrospectivemulticenterstudy
AT patelgargi 186prescriberledantibiotictimeoutalertresponsesaretrospectivemulticenterstudy
AT brophyalison 186prescriberledantibiotictimeoutalertresponsesaretrospectivemulticenterstudy
AT clarkalexander 186prescriberledantibiotictimeoutalertresponsesaretrospectivemulticenterstudy
AT elbagayasmine 186prescriberledantibiotictimeoutalertresponsesaretrospectivemulticenterstudy
AT rajakaran 186prescriberledantibiotictimeoutalertresponsesaretrospectivemulticenterstudy
AT shahmonica 186prescriberledantibiotictimeoutalertresponsesaretrospectivemulticenterstudy
AT stoneelizabeth 186prescriberledantibiotictimeoutalertresponsesaretrospectivemulticenterstudy
AT lewindu 186prescriberledantibiotictimeoutalertresponsesaretrospectivemulticenterstudy